Home Newsletters Cancer Stem Cell News The C-terminal HSP90 Inhibitor NCT-58 Kills Trastuzumab-Resistant Breast Cancer Stem-Like Cells

The C-terminal HSP90 Inhibitor NCT-58 Kills Trastuzumab-Resistant Breast Cancer Stem-Like Cells

Justin.choi

November 15, 2021

Researchers investigated the capacity of NCT-58, a rationally-synthesized C-terminal HSP90 inhibitor, to kill trastuzumab-resistant HER2-positive breast cancer stem-like cells.

[Cell Death Discovery]

Full Article